327 related articles for article (PubMed ID: 34163207)
21. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
Liu F; Wu H
J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
[TBL] [Abstract][Full Text] [Related]
22. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma.
Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C
Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
Song W; Wu X; Wang S; Barr MP; RodrÃguez M; Oh IJ; Wu Y; Li D
Transl Lung Cancer Res; 2023 Dec; 12(12):2476-2493. PubMed ID: 38205213
[TBL] [Abstract][Full Text] [Related]
24. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
[TBL] [Abstract][Full Text] [Related]
25. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
Luo L; Li Y; Zhang L; Yang L
Technol Health Care; 2024 Feb; ():. PubMed ID: 38517815
[TBL] [Abstract][Full Text] [Related]
26. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
[TBL] [Abstract][Full Text] [Related]
27. The Lung Adenocarcinoma Microenvironment Mining and Its Prognostic Merit.
Zhao R; Ding D; Yu W; Zhu C; Ding Y
Technol Cancer Res Treat; 2020; 19():1533033820977547. PubMed ID: 33280515
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
29. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
30. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma.
Peng LS; Duan SL; Li RQ; Wang D; Han YY; Huang T; Yu YP; Ou CL; Wang JP
Front Oncol; 2022; 12():1043862. PubMed ID: 36505798
[TBL] [Abstract][Full Text] [Related]
32. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
[TBL] [Abstract][Full Text] [Related]
33. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
[TBL] [Abstract][Full Text] [Related]
34. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis.
Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ
Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851
[No Abstract] [Full Text] [Related]
35. Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma.
Shao Y; Zheng Z; Li S; Yang G; Qi F; Fei F
J Oncol; 2022; 2022():5185202. PubMed ID: 36245990
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma.
Li X; Chen J; Meng J
Medicine (Baltimore); 2023 Sep; 102(35):e34557. PubMed ID: 37657044
[TBL] [Abstract][Full Text] [Related]
37. MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.
Li M; Ren H; Zhang Y; Liu N; Fan M; Wang K; Yang T; Chen M; Shi P
Front Oncol; 2022; 12():772686. PubMed ID: 35174083
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma.
Hou Y; Xiang B; Yang Z; Liu J; Xu D; Geng L; Zhan M; Xu Y; Zhang B
Int J Immunopathol Pharmacol; 2023; 37():3946320231202748. PubMed ID: 37731383
[No Abstract] [Full Text] [Related]
39. Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma.
Lin L; Lin G; Lin H; Chen L; Chen X; Lin Q; Xu Y; Zeng Y
Front Immunol; 2022; 13():906420. PubMed ID: 36275646
[TBL] [Abstract][Full Text] [Related]
40. RAB11FIP1: An Indicator for Tumor Immune Microenvironment and Prognosis of Lung Adenocarcinoma from a Comprehensive Analysis of Bioinformatics.
Zhang W; Chen T; Liu J; Yu S; Liu L; Zheng M; Liu Y; Zhang H; Bian T; Zhao X
Front Genet; 2021; 12():757169. PubMed ID: 34764984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
